Evolution of Opioids Reimbursement since 2004 from the National Database of the General Health Insurance System
Pauly et al., Thérapie, 2011
La Méphédrone : une designer drug d’usage récent en France
Debruyne et al., Thérapie, 2010
La Méphédrone : une designer drug d’usage récent en France Lire la suite »
Assessment of abuse of Tianeptine from a reimbursement database using “doctor-shopping” as an indicator
Rouby et al., Fundamental & clinical pharmacology, 2012
Evidence of Clonazepam abuse liability: results of the tools developed by the French CEIP network
Frauger et al., Fundamental & clinical pharmacology, 2011
Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures ? Controlling High Dosage Buprenorphine abuse.
Pauly et al., Drug and Alcohol Dependence, 2011
2007, enquête OPPIDUM : consommations de méthadone et de buprénorphine haut dosage
Nordmann et al., Le Courrier des Addictions, 2009
2007, enquête OPPIDUM : consommations de méthadone et de buprénorphine haut dosage Lire la suite »
Le programme de surveillance OPPIDUM du Réseau des CEIPs : 20 ans d’expérience déjà !
Frauger et al., La Lettre du Pharmacologue, 2009
Second Meeting of the French CEIP, part I : How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs ?
Micallef et al., Thérapie, 2009
Estimation of Clonazepam abuse liability: a new method using a reimbursed drug database
Frauger et al., International Clinical Psychopharmacology, 2009